Select the Industry/ Sector šŸ‘‰    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹25,488.5
₹54,161 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,348.6
₹41,844 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,794.6
₹31,066 Cr
Pharmaceuticals & Drugs
₹1,343.5
₹16,494 Cr
Pharmaceuticals & Drugs
₹771.0
₹15,154 Cr
Pharmaceuticals & Drugs
₹718.4
₹11,306 Cr
Pharmaceuticals & Drugs
₹884.9
₹8,024 Cr
Pharmaceuticals & Drugs
₹403.4
₹3,682 Cr
Pharmaceuticals & Drugs
₹259.5
₹2,906 Cr
Pharmaceuticals & Drugs
₹774.6
₹442 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹771.0
₹7,784 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,348.6
₹5,776 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹718.4
₹4,502 Cr
Pharmaceuticals & Drugs
₹403.4
₹2,678 Cr
Pharmaceuticals & Drugs
₹884.9
₹1,969 Cr
Pharmaceuticals & Drugs
₹3,794.6
₹1,593 Cr
Pharmaceuticals & Drugs
₹259.5
₹750 Cr
Pharmaceuticals & Drugs
₹25,488.5
₹7,004 Cr
Pharmaceuticals & Drugs
₹774.6
₹364 Cr
Pharmaceuticals & Drugs
₹1,343.5
₹2,590 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,348.6
₹1,135 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹771.0
₹688 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,794.6
₹439 Cr
Pharmaceuticals & Drugs
₹718.4
₹293 Cr
Pharmaceuticals & Drugs
₹884.9
₹196 Cr
Pharmaceuticals & Drugs
₹403.4
₹191 Cr
Pharmaceuticals & Drugs
₹259.5
₹172 Cr
Pharmaceuticals & Drugs
₹25,488.5
₹1,615 Cr
Pharmaceuticals & Drugs
₹774.6
₹23 Cr
Pharmaceuticals & Drugs
₹1,343.5
₹603 Cr

You may also like the below Video Courses